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Abstract
Background: Elderly patients, in particular, have been reported to develop psychiatric side effects from antibiotics.
Clarithromycin, quinolones, sulfamethoxazole-trimethoprim, isoniazid, penicillin, and cephalosporins have been
reported to cause psychosis. This case report bridges a void in the medical literature with regards to the psychiatric
adverse effects of imipenem-cilastatin.
Case presentation: A 64-year-old Hispanic man in septic shock due to urinary tract infection was initiated on
imipenem-cilastatin and mechanically ventilated, following admission to hospital. His mentation was normal for
72 hours after extubation and discontinuation of sedatives and opioids, following which he was noted to be in
acute psychosis. Our patient’s imipenem-cilastatin dose had been increased 24 hours prior to his violent visual and
auditory hallucinations because his renal function had improved. The physical examination and laboratory tests did
not reveal evidence of a new central nervous infection or endocrinopathy. His mentation improved after his
antibiotic was switched to ceftriaxone, based on culture and sensitivity testing. Similar psychiatric symptoms
developed 2 months later when he was treated with imipenem for a recurrent urinary tract infection. His symptoms
again resolved with modification of his antibiotic regimen.
Conclusions: Endocrine dysfunctions (thyroid, adrenal, and pituitary disorders) and toxic ingestions are medical
disorders known to cause brief psychotic episodes. Fluoroquinolones, penicillins, and trimethoprim-sulfamethoxazole
are common antibiotics associated with this rare adverse effect. Several pharmacokinetic hypotheses have been
proposed for this adverse effect: (1) N-methyl-D-aspartate receptor hypofunctioning, (2) sequential blockade of folic
acid production, (3) inhibition of prostaglandin E2 and proinflammatory cytokine production, (4) increased central
dopamine turnover, and (5) accumulation of toxic levels of the drug. Pre-existing psychopathology, relevant
comorbidities, slow acetylation status, and increased permeability of the blood–brain barrier have been suggested to
make patients more prone to developing psychosis. According to the literature, this psychiatric manifestation resolves
within 2 weeks of discontinuing the offending agent. There appears to be underreporting of the psychiatric
manifestations of imipenem-cilastatin, contrary to post-marketing surveillance data. It is imperative that physicians
recognize these psychiatric side effects of antibiotics, because they are a fundamental treatment option.
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Background
Acute brain dysfunction has been proven to cause
negative clinical outcomes, including increased mortality,
length of hospital stay, and cost of care. Sedatives, opioid
medications, dihydropyridines, and antihistamines are
common classes of medications known to cause delirium
[1]. It has been reported that 12–39 % of cases of delirium
are caused by medication alone [2–4]. Antibiotics have
also been associated with the development of delirium.
There is a very thin line separating delirium from psych-
osis. Elderly patients, in particular, have been reported to
develop psychiatric side effects from antibiotics. The
antibiotics well known to cause psychosis are penicil-
lins, cephalosporins, trimethoprim-sulfamethoxazole,
fluoroquinolones, and antitubercular medications. This
case report bridges a void in medical literature with
regards to the psychiatric adverse effects of imipenem-
cilastatin.
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Case presentation
A 64-year-old Hispanic man with traumatic paraplegia
presented with a urinary tract infection (UTI). He had a
neurogenic bladder and a history of recurrent UTIs
but no prior history of psychiatric diseases. On exam-
ination, he was noted to have a temperature of
100.7 °F (38.17 °C), blood pressure of 93/56 mm Hg,
a pulse of 147 beats per minute, and a respiratory
rate of 28 breaths per minute. He had labored breath-
ing, suprapubic tenderness, and frank pus in his urine
when a urinary catheter was placed. He was emer-
gently intubated and mechanically ventilated because
his cardiorespiratory status deteriorated. At the time
of admission, our patient’s white blood cell (WBC)
count was 16,500/μL (neutrophils 75 %, lymphocyte
12.5 %, and bands 8.4 %). His biochemical parameters
were within physiological limits except for his serum
creatinine at 2.4 mg/dL (estimated glomerular filtra-
tion rate [eGFR], 25 mL/min/1.73 m2) and blood urea
nitrogen (BUN) at 52 mg/dL. Two sets of blood cul-
ture and a urine culture grew Klebsiella pneumoniae
(a final report including the culture antibiotic sensi-
tivity was reported on day 4 of his hospitalization). A
renally adjusted dose of imipenem-cilastatin was initiated
because of his prior history of extended-spectrum beta-
lactamase (ESBL) Klebsiella UTIs. Sedatives were discon-
tinued, and our patient was successfully extubated after he
demonstrated clinical improvement. Our patient was
oriented to place, person, time, and situation after extuba-
tion; an assessment using the Confusion Assessment
Method for the Intensive Care Unit (CAM-ICU) did not
demonstrate any delirium. His family noted that he looked
better and was conversing normally. The dose of
imipenem-cilastatin was readjusted (increased) on his
third day of hospitalization owing to the recovery of his
renal function. On the fourth day of hospitalization, he
was restless and agitated by paranoid thoughts (Fig. 1). He
reported seeing and hearing people from his church
planning to burn him at the stake.
The differential diagnoses entertained at this time
were ICU delirium, encephalitis, endocrine dysfunction,
structural neurological lesions (possibly stroke), or toxic
ingestion. Our patient was oriented to place, person, and
time with no new neurological deficits except for the
visual and auditory hallucinations. Despite having an acute
change in his baseline mental status (Richmond Agitation
Sedation Score [RASS] 0 to 1+), he did not demonstrate
any inattention (as demonstrated by picking ‘2’s) and,
therefore, CAM-ICU was not diagnostic for ICU delirium.
When our patient’s laboratory tests were repeated at the
time of the psychotic symptoms, his WBC count was
9400/μL (neutrophils 74.2 %, lymphocyte 14.2 %). His bio-
chemistry panel revealed serum creatinine of 0.9 mg/dL
(eGFR, 65 mL/min/1.73 m2), BUN of 15 mg/dL, serum
sodium of 138 mEq/L, serum potassium of 4.1 mEq/L,
serum chloride of 102 mEq/L, and serum bicarbonate of
22 mEq/L. His 8 a.m. cortisol level was 18 μg/dL and his
thyroid function was within physiological limits (TSH
1.04 mIU/L, free T4 7.4 μg/dL, and free T3 83 ng/dL). Re-
peat urine and blood cultures performed while he was ex-
periencing psychotic symptoms were later reported to
have tested negative for any infection. Further neuro-
logical imaging or invasive neurological procedures were
not performed because he did not have any new focal
neurological deficits.
Brief psychotic episode was diagnosed as per the fifth
edition Diagnostic and Statistical Manual of Mental Dis-
orders (DSM-5) criteria, and delirium was excluded be-
cause inattention could not be demonstrated. All
reversible causes of psychosis were sought. The only
change in the management of our patient was a change
in the dose of imipenem-cilastatin; this was considered
to be a possible etiology for psychosis. Objective evi-
dence of a causal relationship between the drug and
psychosis was assessed using the Naranjo Probability
Scale. Our patient’s Naranjo adverse drug reaction
(ADR) probability scale score was calculated to be +7;
imipenem-cilastatin was the probable culprit [5].
Imipenem-cilastatin was discontinued, and he was
switched to ceftriaxone according to susceptibilities
from the blood and urine culture. His mood and be-
havior improved; all visual and auditory hallucinations
Fig. 1 Timeline of development and resolution of symptoms with relevant events during the patient’s course of admission and readmission
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resolved by his sixth day of hospitalization. He expe-
rienced similar psychiatric symptoms 2 months later
when imipenem-cilastatin was initiated empirically for
complicated UTI. On this readmission, the Naranjo
ADR probability scale score was +9, definite, when he
was rechallenged with imipenem-cilastatin. His hallu-
cinations resolved within 48 hours of discontinuing
imipenem-cilastatin, as in the first instance. Unfortunately,
on both occasions, the levels of imipenem or cilastatin
were not estimated owing to laboratory and logistic issues.
Discussion
Prior to the third edition of the DSM, many terms
existed to describe generalized brain dysfunction—acute
confusional state, encephalopathy, acute brain failure,
and ICU psychosis—causing terminological chaos. The
American Psychiatric Association, since its third edition
of the DSM, has worked diligently to update the defin-
ition to help clinicians identify delirium in patients of all
ages. DSM-5 does not use the term “consciousness” but
instead restrictively defines delirium in terms of atten-
tion, arousal, and cognition for the purpose of testability.
Alterations in attention and awareness are core to the
diagnosis of delirium. For example, despite an alteration
in his level of consciousness (as evidenced by a change in
RASS score), our patient did not demonstrate inattention,
thereby excluding delirium. Brief psychotic disorder, as de-
fined by DSM-5, is an episode of disturbance lasting at
least a day but less than a month, characterized by one or
more of the following: delusion, hallucination, disorga-
nized speech, and grossly disorganized behavior. These
symptoms should occur in the absence of a mood disorder
or psychosis due to substance use/withdrawal or general
medical condition. Our patient satisfied all the above cri-
teria, with his symptoms occurring after his recovery from
sepsis due to a UTI, when all his biochemical and micro-
biological tests were within normal limits.
Psychotic symptoms in patients being treated with
antibiotics with non-central nervous system (CNS) infec-
tions have been reported in the past. The first docu-
mented case of neuropsychiatric symptoms following
administration of antibiotics was noted with the intra-
muscular administration of penicillin in 1959 [6]. This
disorder was characterized by severe psychomotor agita-
tion with confusion, sensations of depersonalization and
derealization, visual and auditory hallucinations, panic-
like anxiety, and seizures. The term Hoigne’s syndrome
was coined for an acute nonallergic reaction with the
above-mentioned acute psychiatric symptoms to procaine
penicillin.
The exact incidence of antibiotic-associated psychosis
is not well known because of underreporting and an
unknown volume of distribution of the medications. The
majority of the associations between psychosis and
antibiotic treatment in the medical literature are case re-
ports. The common antibiotics associated with the de-
velopment of psychosis are penicillins, cephalosporins,
trimethoprim-sulfamethoxazole, fluoroquinolones, macro-
lides, and antituberculosis medications (Table 1).
Infections are well known to be associated with acute
psychosis. UTIs, in particular, have been noted to cause
acute psychosis in geriatric patients. Manepalli et al.
noted that 20 % of their geriatric patients with acute
psychiatric illness had concomitant UTIs [7]. In a sys-
tematic review by Mostafa and Miller, a causal relation-
ship was demonstrated between antibiotic treatment and
psychosis in 60 % of the reported cases [8]. The
common culprits associated with acute psychosis during
the treatment of UTI were penicillin, trimethoprim-
sulfamethoxazole, and fluoroquinolones. Eight of the 15
patients in the systematic review had a prior history of
psychiatric disorders. In a paper published by the World
Health Organization (WHO), seven of 82 patients re-
ported to have manic episodes with antibiotics use were
concurrently on mood-stabilizing agents [7]. In the
systematic review, 80 % of the patients developed psychi-
atric symptoms within 1 week of initiation of the antibi-
otics [8]. The mean duration of psychotic symptoms was
5.1 days, and seven of the 15 patients required treatment
with antipsychotics. Three of the 15 patients had a
recurrence of symptoms when challenged with the same
antibiotics.
Table 1 Common antibiotics causing psychosis
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The US Food and Drug Administration (FDA)-approved
package insert for imipenem-cilastatin warns against CNS
adverse effects such as seizures, confusional states, and
myoclonic activity. The European Medicines Agency-
approved package insert reports the frequency of
hallucinations due to imipenem-cilastatin to be be-
tween 0.1 % and 1 %. The WHO Collaborating Center
for International Drug monitoring, Uppsala Monitoring
Centre, has 412 reports demonstrating a causal relation-
ship between psychiatric disorders and imipenem-
cilastatin sodium. The most common psychiatric dis-
order associated with imipenem-cilastatin was delirium
(including confusion) with 208 reports, followed by dis-
turbance in thinking and perception (including visual,
auditory, or mixed hallucinations) with 105 reports
[9]. However, a PubMed search {(“imipenem”[MeSH
Terms] OR “imipenem”[All Fields]) AND ((((“mental
disorders”[MeSH Terms] OR (“mental”[All Fields]
AND “disorders”[All Fields]) OR “mental disorders”
[All Fields] OR (“psychiatric”[All Fields] AND “disorder”
[All Fields]) OR “psychiatric disorder”[All Fields]) OR
(“hallucinations”[MeSH Terms] OR “hallucinations”[All
Fields] OR “hallucination”[All Fields])) OR (“psychotic
disorders”[MeSH Terms] OR (“psychotic”[All Fields]
AND “disorders”[All Fields]) OR “psychotic disorders”[All
Fields] OR “psychosis”[All Fields])) OR (“delirium”[MeSH
Terms] OR “delirium”[All Fields]))} for articles related to
imipenem-cilastatin causing psychiatric disorders failed to
yield any results. This demonstrates an underreporting of
the psychiatric adverse effects of imipenem-cilastatin
in medical literature, contrary to post-marketing sur-
veillance data. The early identification of these re-
mediable psychiatric adverse effects could shorten the
length of hospitalization, prevent avoidable mortality,
and prevent eventual dementia.
There are various pharmacokinetic properties of the
antibiotics proposed as hypotheses for these psychiatric
adverse effects. GABA-A receptors are competitively
inhibited by fluoroquinolones, causing an up-regulation
of glutamatergic up-regulation; the resulting deficit in
prefrontal-mediated executive function might induce
psychosis [10]. Antibiotics cause the destruction of
intestinal bacterial flora that produces D–alanine, which
is essential for the normal functioning of the N-methyl-
D-aspartate (NMDA) receptor [11]. Hypofunctioning
NMDA receptors could cause psychosis, again by the
loss of prefrontal control. The sequential blockade of
folic acid production in the CNS has been postulated to
cause the development of psychiatric symptoms in
patients on sulfamethoxazole-trimethoprim. Psychosis
associated with indomethacin has been attributed to
the inhibition of prostaglandin E2 and proinflamma-
tory cytokines. It has been postulated that macrolide
antibiotics may also have similar anti-inflammatory
properties, increasing central dopamine turnover, leading
to psychosis [12].
Conclusions
There is a very thin line between medication-induced
delirium and medication-induced acute brief psychosis,
but these conditions are reversible. Case reports record
the resolution of psychiatric symptoms within 2 weeks
of stopping the offending medication. Some patients
may require neuroleptic medications. The treatment of
this condition begins with identifying the culprit medica-
tion and suspension of the same. It is imperative that
physicians recognize the psychiatric side effects of anti-
biotics because they are a fundamental treatment option.
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